Literature DB >> 34344639

Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study.

Enrico Attardi1, Sofia Pilerci1, Irene Attucci1, Alessandra Buzzichelli1, Maria Messeri1, Michela Staderini2, Alessandro M Vannucchi3, Elisabetta Antonioli4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34344639     DOI: 10.1016/j.clml.2021.06.018

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


× No keyword cloud information.
  2 in total

1.  Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma.

Authors:  Francesca Bonello; Serena Rocchi; Gregorio Barilà; Michela Sandrone; Marco Talarico; Elena Zamagni; Matilde Scaldaferri; Susanna Vedovato; Cecilia Bertiond; Laura Pavan; Sara Bringhen; Francesco Cattel; Renato Zambello; Michele Cavo; Roberto Mina
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

Review 2.  Toxicity management strategies for next-generation novel therapeutics in multiple myeloma.

Authors:  Mary Steinbach; Kelley Julian; Brian McClune; Douglas W Sborov
Journal:  Ther Adv Hematol       Date:  2022-07-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.